Cordis to Present SELUTION SLR™ Drug-Eluting Balloon Clinical Data at CRT 2026
Cordis, a global leader in interventional cardiovascular technologies, will highlight insights from the SELUTION SLR™ Drug-Eluting Balloon (DEB) clinical trial program at Cardiovascular Research Technologies (CRT) 2026, March 7–10 in Washington, D.C. Presentations will include the 12-month results of SELUTION4ISR and SELUTION DeNovo trials along with new subset analyses from the SELUTION DeNovo study.
